MWA With or Without Furmonertinib for Early-Stage Non-Small Cell Lung Cancer
MWA With or Without Furmonertinib for Early-Stage Non-Small Cell Lung Cancer
Not yet recruiting · NCT06969781 · Registry updated 2025-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MWA With or Without Furmonertinib for Early-Stage Non-Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Not applicable | 2025-05-14 | NCT06969781 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Allist Pharmaceuticals Co.,Ltd. | 1 |
| Shanghai Chest Hospital | 116 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||